PROCEPT BioRobotics Corporation Increase (Decrease) in Prepaid Expense and Other Assets
PROCEPT BioRobotics Corporation (PRCT) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$1.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-05
- PROCEPT BioRobotics Corporation increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$799.00K.
- PROCEPT BioRobotics Corporation increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$1.17M.
- PROCEPT BioRobotics Corporation increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $431.00K, a 78.46% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $1.76M, a 33.33% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in prepaid expense and other assets for fiscal 2025 was $1.10M, a 65.68% decline from fiscal 2024.
- PROCEPT BioRobotics Corporation increase (decrease) in prepaid expense and other assets for fiscal 2024 was $3.21M.
- PROCEPT BioRobotics Corporation increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.05M, a 155.90% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation increase (decrease) in prepaid expense and other assets for fiscal 2022 was $1.88M, a 28.54% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$799.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.97M 10-Q · filed 2026-08-05 | -$1.53M derived: sum of 3 quarters · filed 2026-08-05 | $225.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$1.17M 10-Q · filed 2026-04-30 | -$736.00K derived: sum of 2 quarters · filed 2026-04-30 | $1.02M derived: sum of 3 quarters · filed 2026-04-30 | $511.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $431.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.19M derived: sum of 2 quarters · filed 2026-02-26 | $1.68M derived: sum of 3 quarters · filed 2026-08-05 | $1.10M 10-K · filed 2026-02-26 |
| 2025-09-30 | $1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.25M derived: sum of 2 quarters · filed 2026-08-05 | $671.00K 10-Q · filed 2025-11-05 | $2.67M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$513.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.09M 10-Q · filed 2026-08-05 | $912.00K derived: sum of 3 quarters · filed 2026-08-05 | $2.23M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$576.00K 10-Q · filed 2026-04-30 | $1.43M derived: sum of 2 quarters · filed 2026-04-30 | $2.75M derived: sum of 3 quarters · filed 2026-04-30 | $1.96M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $3.32M derived: sum of 2 quarters · filed 2026-02-26 | $2.53M derived: sum of 3 quarters · filed 2026-02-26 | $3.21M 10-K · filed 2026-02-26 |
| 2024-09-30 | $1.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $531.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.21M 10-Q · filed 2025-11-05 | $2.35M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$789.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$110.00K 10-Q · filed 2025-08-07 | $1.03M derived: sum of 3 quarters · filed 2026-02-26 | $1.27M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $679.00K 10-Q · filed 2025-05-02 | $1.82M derived: sum of 2 quarters · filed 2026-02-26 | $2.06M derived: sum of 3 quarters · filed 2026-02-26 | $1.56M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.38M derived: sum of 2 quarters · filed 2026-02-26 | $880.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.05M 10-K · filed 2026-02-26 |
| 2023-09-30 | $241.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | -$263.00K derived: sum of 2 quarters · filed 2024-10-28 | -$2.19M 10-Q · filed 2024-10-28 | -$316.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$504.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | -$2.44M 10-Q · filed 2024-08-02 | -$557.00K derived: sum of 3 quarters · filed 2025-02-27 | -$84.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$1.93M 10-Q · filed 2024-05-02 | -$53.00K derived: sum of 2 quarters · filed 2025-02-27 | $420.00K derived: sum of 3 quarters · filed 2025-02-27 | $126.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.88M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.35M derived: sum of 2 quarters · filed 2025-02-27 | $2.06M derived: sum of 3 quarters · filed 2025-02-27 | $1.88M 10-K · filed 2025-02-27 |
| 2022-09-30 | $473.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $179.00K derived: sum of 2 quarters · filed 2023-11-02 | $2.00K 10-Q · filed 2023-11-02 | $2.03M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$471.00K 10-Q · filed 2023-07-28 | $1.55M derived: sum of 3 quarters · filed 2024-02-28 | $748.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$177.00K 10-Q · filed 2023-05-04 | $1.85M derived: sum of 2 quarters · filed 2024-02-28 | $1.04M derived: sum of 3 quarters · filed 2024-02-28 | $2.03M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $1.22M derived: sum of 2 quarters · filed 2024-02-28 | $2.21M derived: sum of 3 quarters · filed 2024-02-28 | $2.63M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$806.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $186.00K derived: sum of 2 quarters · filed 2022-11-04 | $606.00K 10-Q · filed 2022-11-04 | $745.00K derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $992.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.41M 10-Q · filed 2022-08-05 | $1.55M derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | $420.00K 10-Q · filed 2022-05-06 | $559.00K derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $339.00K 10-K · filed 2022-03-22 | ||
| 2020-09-30 | $200.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |